INC Research Ranked "Top CRO to Work With" Among Large

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
INC Research Ranked "Top CRO to Work With" Among Large Global CROs for a Second Straight Time in Biannual CenterWatch Survey

RALEIGH, N.C., April 1, 2015 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq: INCR ), a leading, global Phase I to IV contract research organization, is ranked "Top CRO to Work With" among large global CROs in the biannual CenterWatch Global Investigative Site Relationship Survey. Results of the 2015 survey were published earlier today by CenterWatch, the leading provider of global clinical trials information. INC Research also received the top ranking in CenterWatch's most recent global investigative site relationship survey completed in 2013 and is the only CRO to rank consistently among the top three CROs in all seven CenterWatch site relationship surveys conducted since 2007.

"INC Research's ranking is a direct reflection of our continued dedication to supporting clinical research sites globally, leveraging their insights to improve drug development and providing optimal support to ensure their success," says Chief Executive Officer Jamie Macdonald. "Our therapeutically aligned teams understand the pain points for sites and are able to work with them more effectively to ease these challenges and improve clinical development. Through many years of working with sites, our team has focused on growing deeper site relationships and making sites feel fully supported on every trial."

INC Research's top ranking in the CenterWatch survey reflects the Company's continued and significant focus on site relationships to enhance its delivery of global clinical development programs for biopharmaceutical customers worldwide. INC Research is a Global Impact Partner and Circle of Sustainability Sponsor (the highest level of partnership) with the Society for Clinical Research Sites (SCRS), the global trade organization fully dedicated to representing the interests of clinical research sites. INC is the first and only CRO to sponsor SCRS scholarships to provide sites across the globe the benefit of training and mentoring gained through SCRS membership. The Company is also the first and only CRO to utilize Site Advocacy Groups, a new forum providing valuable perspectives from sites earlier in the clinical trials process leading to greater predictability in performance and improved site sustainability. INC is committed to recognizing the contributions of its site partners globally through programs such as the INC Research Clinical Research Site Award, through which more than 100 awards were given in 2014.

"Clinical research sites are critical to the drug development process and it is important we continue to recognize their contributions and provide the support they need to be successful," says Clare Grace, Vice President, Site and Patient Access. "INC has long valued quality site relationships and fosters a collaborative approach to activities and deliverables. We work closely with sponsors and sites to develop a common understanding of expectations and standardize processes to enhance research and reach shared goals. Ultimately, we all work together to improve the lives of patients through medical research."

CenterWatch's 2015 Global Investigative Site Relationship Survey was conducted online between October 2014 and January 2015 and included participation from principal investigators, sub-investigators and study coordinators at more than 1,900 sites. INC Research's combined excellent/good ratings and average excellent ratings in the 2015 CenterWatch survey were higher compared to 2013 survey results, a testament to the Company's commitment to continuous improvement under its Trusted Process ® driving engagement with sites as key stakeholders in the clinical trials process. Rankings in the CenterWatch survey are based on a combination of two measures: an overall relationship quality rating based on "excellent" scores from sites, and the frequency with which companies placed among the top-three rated CROs across all relationship attributes measured.

About INC Research

INC Research (Nasdaq: INCR ) is a leading global contract research organization (CRO) providing the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry. Leveraging the breadth of our service offerings and the depth of our therapeutic expertise across multiple patient populations, INC Research connects customers, clinical research sites and patients to accelerate the delivery of new medicines to market. The Company was ranked the "Top CRO to Work With" among large global CROs in the 2015 CenterWatch Global Investigative Site Relationship Survey. INC Research is headquartered in Raleigh, N.C., with operations across six continents and experience spanning more than 100 countries. For more information, please visit www.incresearch.com and connect with us on LinkedIn and Twitter @inc_research .

Investors: Ronnie Speight, +1 919 745 2745 Media: Lee Kennedy, +1 919 666 0772

Scroll down for more posts ▼

Top 10 Most Recent News Articles

&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 34

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
SAFE Wins Missouri Guard UH-60 Platform Contract Again

Updated Category News Views 30

Helicopter maintenance is one of those businesses where a few feet of floor space can matter more than a glossy brochure full of promises. SAFE Structure Designs has landed a new contract to supply custom wraparound maintenance platforms for UH-60 helicopters at the Missouri Army National Guard facility in Springfield, Missouri. No price was disclosed, no delivery...

Continue Reading
LGT Middle East Win Highlights Patient Private Banking

Updated Category News Views 120

A trophy in Dubai is not a balance sheet, but it can be a useful calling card when the clientele measures relationships in decades rather than quarters. LGT Middle East was named Best Pure Play Private Bank at the WealthBriefing MENA Awards 2026, at a ceremony held in Dubai on November 18. For a family-owned wealth manager working with Middle Eastern families, that sort...

Continue Reading
Dubai's 2028 Fire Congress Puts Global Safety Tech on Stage

Updated Category News Views 77

Fire engines, wildfires, dense towers, and AI are all colliding in Dubai's next big public-safety moment. The World Fire Congress has handed its 2028 host role to Dubai, making this the first time the biennial gathering of global fire and emergency-service leaders will land in the Middle East. That is not a quarterly earnings event, and nobody ought to pretend it is....

Continue Reading
First US Extends Buyback Clock Through Year-End 2027

Updated Category News Views 199

A buyback extension is not a thunderclap; it is a bank board keeping a useful tool within reach. First US Bancshares has pushed the expiration of its existing repurchase authorization from December 31, 2026, to December 31, 2027. That matters, but investors ought to resist turning a calendar change into a grand earnings prophecy. The company has bought back 2,122,972...

Continue Reading
ROHM's GaN PFC Chip Targets the Power-Supply Squeeze

Updated Category News Views 72

Power supplies are where a lot of sleek electronics quietly lose the plot, and ROHM is taking a proper swing at that problem. Its new BM85060FV is a totem-pole power factor correction controller built for gallium nitride, or GaN, high-frequency switching in AC-DC power supplies. The headline is not subtle: ROHM says a 300 to 500 W system using the chip can reach 99%...

Continue Reading
CHN Energy's Indonesia Record Deserves a Hard Look

Updated Category News Views 87

Twenty years of boots sinking into swamp mud tells a sturdier story than a polished anniversary slogan. CHN Energy says it entered Indonesia's energy market two decades ago and has since built an operating presence around reliable electricity, local training and community work. In a country scattered across thousands of islands, dependable power is not some decorative...

Continue Reading
Ajman Forum Puts Algorithmic Messaging Under Scrutiny

Updated Category News Views 53

Algorithms do not merely shuffle posts anymore; they can scramble confidence in the institutions people depend on. That was the serious undercurrent at Ajman Media Forum 2026 – THE SIGNAL, where a session on who leads the government message in an algorithm-driven age brought the discussion back to an uncomfortable reality: communication, cybersecurity and social...

Continue Reading
Makera A1S Tests the Desktop CNC Metal-Cutting Promise

Updated Category News Views 21

Aluminum chips are where desktop-machine marketing stops bluffing, and Makera is leaning right into that test with the A1S. The company opened global pre-orders on November 18 for a machine aimed squarely at the awkward middle ground: users who have outgrown entry-level hobby gear but do not have room, budget, or patience for a full industrial setup. That is a real market...

Continue Reading
Star Catcher Powers a Public-Interest Space Bet Ahead

Updated Category News Views 94

A satellite’s battery budget is a rotten place for humanitarian priorities to die. Common Space and Star Catcher are trying to remove that bottleneck through a partnership that is easy to like on principle and still deserves a clear-eyed look on execution. Common Space, a nonprofit developing an independent, community-governed high-resolution satellite constellation,...

Continue Reading

Top 5 Most Recently Viewed Articles

commercetools Compilations: Innovations Driving Digital Growth

Updated Category News Views 177

Exciting Launch of commercetools Compilations commercetools has unveiled Compilations, a semi-annual showcase that highlights more than 50 product enhancements, demonstrating the organization’s dedication to innovation and improved customer experiences for users of the commercetools Platform. With over 13,000 deployments and 200 releases, this initiative significantly...

Continue Reading
Join the Class Action Against Red Cat Holdings, Inc. Today

Updated Category News Views 185

Understanding the Class Action Against Red Cat Holdings, Inc. Red Cat Holdings, Inc. is currently under the spotlight due to a class action securities lawsuit filed by the law firm Levi & Korsinsky, LLP. The firm is reaching out to investors who believe they have incurred losses due to the alleged securities fraud that transpired between a specified period. If you have...

Continue Reading
GRAIL Initiates Patient Testing with Innovative Blood Test for Lung Cancer

Updated Category News Views 127

GRAIL Announces Milestone in Lung Cancer Detection GRAIL, Inc. (Nasdaq: GRAL), a pioneering healthcare firm focused on early cancer detection, has achieved a significant milestone by announcing that the first patient has been assessed for eligibility through its innovative non-small cell lung cancer (NSCLC) ctDNA Assay. This groundbreaking development occurs within the...

Continue Reading
Neurocrine Biosciences Enhances Collaboration with Takeda

Updated Category News Views 197

Neurocrine Biosciences Enhances Collaboration with Takeda Neurocrine Biosciences, Inc. (NASDAQ: NBIX) has recently announced an amendment to strengthen the strategic collaboration with Takeda. This partnership focuses on the development and commercialization of osavampator, an innovative therapeutic candidate that holds promise for patients suffering from major depressive...

Continue Reading
LivaNova Prepares to Reveal 2024 Year-End Financials

Updated Category News Views 94

LivaNova's Upcoming Financial Announcement LivaNova PLC (Nasdaq: LIVN), a prominent player in the medical technology sector, is gearing up for an important event. The company will hold a conference call in which they will discuss their financial results from the fourth quarter as well as the entire year of 2024. This event is slated for a Tuesday afternoon and is expected...

Continue Reading